To evaluate the contribution of tumor cell-intrinsic STING activation to the anti-tumor activity of the ADCs, we utilized the Fc-mutant ADCs, which lack FcγR-binding and therefore do not activate STING in myeloid cells (Fig. 1d–g). Here, FCGR2A is linked to neoplasm.